184 related articles for article (PubMed ID: 22251800)
1. DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4).
Quentmeier H; Eberth S; Romani J; Weich HA; Zaborski M; Drexler HG
BMC Cancer; 2012 Jan; 12():19. PubMed ID: 22251800
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation, induced by beta-carotene and arachidonic acid, plays a regulatory role in the pro-angiogenic VEGF-receptor (KDR) gene expression in endothelial cells.
Kiec-Wilk B; Razny U; Mathers JC; Dembinska-Kiec A
J Physiol Pharmacol; 2009 Dec; 60(4):49-53. PubMed ID: 20065496
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation status of VEGF receptor genes: a possible epigenetic biomarker to anticipate the efficacy of intracellular-acting VEGF-targeted drugs in cancer cells.
Kim J; Hwang J; Jeong H; Song HJ; Shin J; Hur G; Park YW; Lee SH; Kim J
Epigenetics; 2012 Feb; 7(2):191-200. PubMed ID: 22395469
[TBL] [Abstract][Full Text] [Related]
4. The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation.
Kim JY; Hwang JH; Zhou W; Shin J; Noh SM; Song IS; Kim JY; Lee SH; Kim J
Epigenetics; 2009 Jul; 4(5):313-21. PubMed ID: 19633424
[TBL] [Abstract][Full Text] [Related]
5. The expression of vascular endothelial growth factor and its receptors (flt1/fms, flk1/KDR, flt4) and vascular endothelial growth inhibitor in the bovine uterus during the sexual cycle and their correlation with serum sex steroids.
Sağsöz H; Saruhan BG
Theriogenology; 2011 Jun; 75(9):1720-34. PubMed ID: 21396695
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H
BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation profiles and biomarkers of oral squamous cell carcinoma.
Li YF; Hsiao YH; Lai YH; Chen YC; Chen YJ; Chou JL; Chan MW; Lin YH; Tsou YA; Tsai MH; Tai CK
Epigenetics; 2015; 10(3):229-36. PubMed ID: 25612142
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.
Misawa Y; Misawa K; Kawasaki H; Imai A; Mochizuki D; Ishikawa R; Endo S; Mima M; Kanazawa T; Iwashita T; Mineta H
Tumour Biol; 2017 Jul; 39(7):1010428317711657. PubMed ID: 28718364
[TBL] [Abstract][Full Text] [Related]
9. [Effect of recombinant VEGF-C secreted from eukaryotic cells on proliferation and chemotherapy-induced apoptosis of leukemic cells].
Ding KY; Bai X; Dai L; Dong NZ; Ruan CG
Ai Zheng; 2005 Sep; 24(9):1037-42. PubMed ID: 16159421
[TBL] [Abstract][Full Text] [Related]
10. Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia.
Fielder W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK
Leukemia; 1997 Aug; 11(8):1234-7. PubMed ID: 9264375
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of inhibition of the abnormal proliferation of human umbilical vein endothelial cells by hydroxysafflor-yellow A.
Wang J; Wang J; Wang X; Liu L; Hu J; Yu X; Xu Y; Niu X; Lin Z; Zhang Y; Zhang X; Zhang Q
Pharm Biol; 2016 Sep; 54(9):1800-7. PubMed ID: 26730646
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary Differences in the Vegf/Vegfr Code Reveal Organotypic Roles for the Endothelial Cell Receptor Kdr in Developmental Lymphangiogenesis.
Vogrin AJ; Bower NI; Gunzburg MJ; Roufail S; Okuda KS; Paterson S; Headey SJ; Stacker SA; Hogan BM; Achen MG
Cell Rep; 2019 Aug; 28(8):2023-2036.e4. PubMed ID: 31433980
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells.
Zhang H; Wu J; Meng L; Shou CC
World J Gastroenterol; 2002 Dec; 8(6):994-8. PubMed ID: 12439912
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1.
Kilic N; Oliveira-Ferrer L; Neshat-Vahid S; Irmak S; Obst-Pernberg K; Wurmbach JH; Loges S; Kilic E; Weil J; Lauke H; Tilki D; Singer BB; Ergün S
Blood; 2007 Dec; 110(13):4223-33. PubMed ID: 17761831
[TBL] [Abstract][Full Text] [Related]
15. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
16. [Coexpression of vascular endothelial growth factor and its receptors in human tumor cell lines].
Fu JX; Wang W; Bai X; Wang L; Zhu ZL; Chen ZX; Ruan CG
Ai Zheng; 2002 Nov; 21(11):1217-21. PubMed ID: 12526219
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
[TBL] [Abstract][Full Text] [Related]
18. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells.
Doi Y; Yashiro M; Yamada N; Amano R; Noda S; Hirakawa K
Ann Surg Oncol; 2012 Aug; 19(8):2733-43. PubMed ID: 22207048
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell-specific chemotaxis receptor (ECSCR) enhances vascular endothelial growth factor (VEGF) receptor-2/kinase insert domain receptor (KDR) activation and promotes proteolysis of internalized KDR.
Kilari S; Remadevi I; Zhao B; Pan J; Miao R; Ramchandran R; North PE; You M; Rahimi N; Wilkinson GA
J Biol Chem; 2013 Apr; 288(15):10265-74. PubMed ID: 23393131
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.
Hervé MA; Meduri G; Petit FG; Domet TS; Lazennec G; Mourah S; Perrot-Applanat M
J Endocrinol; 2006 Jan; 188(1):91-9. PubMed ID: 16394178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
